Amgen wins latest round in legal tussle over Enbrel patents

Amgen’s reputation as a fearsome adversary in the courtroom remains intact after it won the latest round in a legal tussle with Sandoz over the patent covering the blockbuster inflammatory

AbbVie won’t enforce patents for COVID-19 drug candidate Kal...

Biogen claims victory in patent dispute with Mylan over MS d...

Alexion’s biosimilar-blocking EU patent play for Soliris fai...

Celgene gets US patent let-off ahead of BMS merger

Shares in Celgene ticked up yesterday after a let-off in a US court case challenging the patents on its multi-billion dollar cancer drug Revlimid, a decision that could ease shareholder ten

Indivior hit hard as generic Suboxone defence crumbles

Indivior has suffered a critical defeat in the US courts for opioid addiction product Suboxone Film, opening the door to generic competition and sparking a run on its shares.